glp-1 news today october 23 2025 How the rise of drugs is shifting consumer habits GLP-1 Pipeline Update: May 2025

Conclusion: Meeting the moment The GLP-1 market is expanding rapidlyand so is the pressure on manufacturers to scale quickly

This fleeting action is sufficient for meal-to-meal regulation but limits its therapeutic potential in its natural form

The survey was performed during April and May of 2025

HSA/FSA eligibility for prescription medications prescribed by licensed providers is generally established under IRS guidelines when the cost is for a qualified medical expense

In the first trial, liraglutide lowered weight by 12 pounds and improved glucose tolerance relative to placebo over 4 months in 103 patients with schizophrenia spectrum disorders (Larsen JR et al, JAMA Psych 2017;74(1):719728)